Anti-LIM Kinase 1 antibody [EPR912]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal LIM Kinase 1 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.
View Alternative Names
LIMK, LIMK1, LIM domain kinase 1, LIMK-1
- WB
Unknown
Western blot - Anti-LIM Kinase 1 antibody [EPR912] (AB108507)
All lanes:
Western blot - Anti-LIM Kinase 1 antibody [EPR912] (ab108507) at 1/1000 dilution
Lane 1:
U-87 MG cell lysate at 10 µg
Lane 2:
SH SY5Y cell lysate at 10 µg
Lane 3:
Ramos cell lysate at 10 µg
Predicted band size: 73 kDa
false
Related conjugates and formulations (1)
-
Anti-LIM Kinase 1 antibody [EPR912] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This kinase modulates cell shape migration and differentiation by influencing actin filament networks. LIMK1 associates with regulatory complexes and interacts with several proteins to facilitate cytoskeletal reorganization. It plays an essential part in neural development and synaptic plasticity affecting learning and memory. By phosphorylating key actin-binding proteins like cofilin LIMK1 alters actin dynamics essential for various cellular functions.
Pathways
LIM Kinase 1 influences the RhoA/ROCK and Rac1/Pak pathways both critical for cytoskeletal rearrangements. Within these pathways LIMK1 interacts closely with proteins such as cofilin and is influenced by upstream activators like Rho GTPases. These pathways link it to a broader network of signaling that controls cell movement and stability important for cellular responses in various environmental contexts.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 54: PubMed39301627
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 79:498 PubMed36008729
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biology open 9: PubMed31988091
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 58:2065-2076 PubMed31432570
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 233:6088-6097 PubMed29319181
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:58728-58737 PubMed28938591
2017
Applications
WB
Species
Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com